Faecal immunotesting and faecal calprotectin for IBD

• Research type

  Research Study

• Full title

  Combined faecal immunochemical testing and faecal calprotectin and their potential use in the diagnosis of bowel complications and their application in bowel cancer screening.

• IRAS ID

  206928

• Contact name

  Victoria Clough

• Contact email

  victoria.clough@bhrhospitals.nhs.uk

• Sponsor organisation

  Barking Havering and Redbridge University NhS Trust

• Duration of Study in the UK

  0 years, 3 months, 1 days

• Research summary

  To assess whether combined faecal immunochemical testing and faecal calprotectin can be used to successfully screen patients at Queens hospital for IBD, eliminating the need for colonoscopy's in the screening for IBD. Also, to use these tests in combination to identify more serious conditions as bowel cancers and the possibility for potential earlier identification of bowel disorders.

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  16/SC/0495

• Date of REC Opinion

  5 Sep 2016

• REC opinion

  Favourable Opinion